239 related articles for article (PubMed ID: 18685493)
1. E-cadherin and beta-catenin loss of expression related to bone metastasis in prostate cancer.
Pontes J; Srougi M; Borra PM; Dall' Oglio MF; Ribeiro-Filho LA; Leite KR
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):179-84. PubMed ID: 18685493
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone.
Saha B; Arase A; Imam SS; Tsao-Wei D; Naritoku WY; Groshen S; Jones LW; Imam SA
Prostate; 2008 Jan; 68(1):78-84. PubMed ID: 18008331
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin and beta-catenin are down-regulated in prostatic bone metastases.
Bryden AA; Hoyland JA; Freemont AJ; Clarke NW; Schembri Wismayer D; George NJ
BJU Int; 2002 Mar; 89(4):400-3. PubMed ID: 11872032
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.
Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of E-cadherin and beta-catenin in human prostate cancer.
Jaggi M; Johansson SL; Baker JJ; Smith LM; Galich A; Balaji KC
Urol Oncol; 2005; 23(6):402-6. PubMed ID: 16301117
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.
Chen G; Shukeir N; Potti A; Sircar K; Aprikian A; Goltzman D; Rabbani SA
Cancer; 2004 Sep; 101(6):1345-56. PubMed ID: 15316903
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F
Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
[TBL] [Abstract][Full Text] [Related]
10. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
11. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
Liu J; Ikeguchi M; Nakamura S; Kaibara N
J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
[TBL] [Abstract][Full Text] [Related]
12. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
[TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.
Joo YE; Rew JS; Park CS; Kim SJ
Pancreatology; 2002; 2(2):129-37. PubMed ID: 12123093
[TBL] [Abstract][Full Text] [Related]
14. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.
Morton RA; Ewing CM; Nagafuchi A; Tsukita S; Isaacs WB
Cancer Res; 1993 Aug; 53(15):3585-90. PubMed ID: 8339265
[TBL] [Abstract][Full Text] [Related]
15. Expression of the E-cadherin-catenin complex in patients with pancreatic ductal adenocarcinoma.
Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J
Folia Histochem Cytobiol; 2010 Jan; 48(1):128-33. PubMed ID: 20529828
[TBL] [Abstract][Full Text] [Related]
16. The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and beta-catenin, in prostate cancer.
Contreras HR; Ledezma RA; Vergara J; Cifuentes F; Barra C; Cabello P; Gallegos I; Morales B; Huidobro C; Castellón EA
Urol Oncol; 2010; 28(5):534-40. PubMed ID: 19450993
[TBL] [Abstract][Full Text] [Related]
17. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
[TBL] [Abstract][Full Text] [Related]
18. Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone.
Saha B; Kaur P; Tsao-Wei D; Naritoku WY; Groshen S; Datar RH; Jones LW; Imam SA
Prostate; 2008 Nov; 68(15):1681-8. PubMed ID: 18712716
[TBL] [Abstract][Full Text] [Related]
19. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.
Ewing CM; Ru N; Morton RA; Robinson JC; Wheelock MJ; Johnson KR; Barrett JC; Isaacs WB
Cancer Res; 1995 Nov; 55(21):4813-7. PubMed ID: 7585512
[TBL] [Abstract][Full Text] [Related]
20. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
